TrialProstate cancer and prostatic diseases2025

Impact of a rash management guide in patients receiving apalutamide for high-risk localized prostate cancer in the Apa-RP study.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.